References
- Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010; 46(4): 765-781.10.1016/j.ejca.2009.12.01420116997
- Lung cancer incidence and mortality worldwide in 2008. Summary. ( http://globocan.iarc.fr/factsheets/cancers/lung.asp
- Lonardo F, Li X, Kaplun A, Soubani A, Sethi S, Gadgeel S, Sheng S. The natural tumor suppressor protein maspin and potential application in non small cell lung cancer. Curr Pharm Des. 2010; 16(16): 1877-1881.10.2174/138161210791208974290849520337574
- Sculier JP, Chansky K, Crowley JJ, Van Meerbeeck J, Goldstraw P; International Staging Committee and Participating Institutions. The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the proposals for the 7th Edition. J Thorac Oncol. 2008; 3(5): 457-466.10.1097/JTO.0b013e31816de2b818448996
- Valerianova ZG, Vukov MI, Dimitrova NE, Eds. Cancer Incidence in Bulgaria 2006, 1st ed. Sofia: AVIS-24 Ltd, 2008.
- Zochbauer-Muller S, Gazdar AF, Minna JD. Molecular pathogenesis of lung cancer. Annu Rev Physiol. 2002; 64: 681-708.10.1146/annurev.physiol.64.081501.15582811826285
- Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, Dunant A, Torri V, Rosell R, Seymour L, Spiro SG, Rolland E, Fossati R, Aubert D, Ding K, Waller D, Le Chevalier T; LACE Collaborative Group. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol. 2008; 26(21): 3552-3559.10.1200/JCO.2007.13.903018506026
- Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V, Sobin L; International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007; 2(8): 706-714.10.1097/JTO.0b013e31812f3c1a17762336
- Fulda S. Tumor resistance to apoptosis. Int J Cancer. 2009; 124(3): 511-515.10.1002/ijc.2406419003982
- Horn L, Sandler A. Epidermal growth factor receptor inhibitors and antiangiogenic agents for the treatment of non-small cell lung cancer. Clin Cancer Res. 2009; 15(16): 5040-5048.10.1158/1078-0432.CCR-09-0520352818219671872
- Schulz WA. Apoptosis and replicative senescence in cancer. In: Schulz WA, Ed. Molecular Biology of Human Cancers. Dordrecht: Springer Science + Business Media. 2005: 145.
- Kang BN, Ahmad AS, Saleem S, Patterson RL, Hester L, Doré S, Snyder SH. Death-associated protein kinase-mediated cell death modulated by interaction with DANGER. J Neurosci. 2010; 30(1): 93-98.10.1523/JNEUROSCI.3974-09.2010284072020053891
- Jang CW, Chen CH, Chen CC, Chen J, Su YH, Chen RH. TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase. Nature Cell Biol. 2001; 4(1): 51-58.10.1038/ncb73111740493
- Mashkova TD, Oparina NIu, Zinov'eva OL, Kropotova ES, Dubovaia VI, Poltaraus AB, Fridman MV, Kopantsev EP, Vinogradova TV, Zinov'eva MV, Laktionov KK, Kasymova OT, Zborovskaia IB, Sverdlov ED, Kiselev LL. Transcription TIMP3, DAPk1 and AKR1B10 genes in squamous cell lung cancer. Mol Biol (Mosk). 2006; 40(6): 1047-1054.10.1134/S002689330606014817209422
- Han W, Wang T, Reilly AA, Keller SM, Spivack SD. Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients. Respir Res. 2009; 10: 86.10.1186/1465-9921-10-86275991619781081
- Wang Y, Zhang D, Zheng W, Luo J, Bai Y, Lu Z. Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray. Cancer. 2008; 112(6): 1325-1336.10.1002/cncr.2331218286531
- Liu Y, Gao W, Siegfried JM, Weissfeld JL, Luketich JD, Keohavong P. Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers. BMC Cancer. 2007; 7: 74.10.1186/1471-2407-7-74187781217477876
- Logue SE, Martin SJ. Caspase activation cascades in apoptosis. Biochem Soc Trans. 2008; 36(Pt. 1): 1-9.10.1042/BST036000118208375
- Neumann L, Pforr C, Beaudouin J, Pappa A, Fricker N, Krammer PH, Lavrik IN, Eils R. Dynamics within the CD95 death-inducing signaling complex decide life and death of cells. Mol Syst Biol. 2010; 6: 352.10.1038/msb.2010.6285844220212524
- Yang Q, Kiernan CM, Tian Y, Salwen HR, Chlenski A, Brumback BA, London WB, Cohn SL. Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome. Clin Cancer Res. 2007; 13(11): 3191-3197.10.1158/1078-0432.CCR-06-284617545522
- Stupack DG, Teitz T, Potter MD, Mikolon D, Houghton PJ, Kidd VJ, Lahti JM, Cheresh DA. Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature. 2006; 439(7072): 95-99.10.1038/nature0432316397500
- Su H, Bidere N, Zheng L, Cubre A, Sakai K, Dale J, Salmena L, Hakem R, Straus S, Lenardo M. Requirement for caspase-8 in NF-kappa-B activation by antigen receptor. Science. 2005; 307(5714): 1465-1468.10.1126/science.110476515746428
- Bae J, Leo CP, Hsu SY, Hsueh AJW. MCL1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain. J Biol Chem. 2000; 275(33): 25255-25261.10.1074/jbc.M90982619910837489